Figure 1From: Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosisOverall Survival after Recurrence in the enrolled cases The rates for the 5- and 10-year overall survival were 63.5% and 48%, respectively, indicating a good prognosis for the study groups.Back to article page